Evidence map›Paper›PMID 36430296›Full record

ArticleInternational journal of molecular sciences2022

High Glucose-Induced Cardiomyocyte Damage Involves Interplay between Endothelin ET-1/ET

Sudhir Pandey, Corina T Madreiter-Sokolowski, Supachoke Mangmool, Warisara Parichatikanond

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Mechanisms underlying atrial fibrillation in chronic kidney disease.Journal of molecular and cellular cardiology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Sudhir PandeyDepartment of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok 10400, Thailand.
Corina T Madreiter-SokolowskiMolecular Biology and Biochemistry, Gottfried Schatz Research Center, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0002-8631-9949
Supachoke MangmoolDepartment of Pharmacology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.ORCID 0000-0003-3223-1551
Warisara ParichatikanondDepartment of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok 10400, Thailand.ORCID 0000-0001-7851-2477
Mahidol University · THMedical University of Graz · AT

Funding

Austrian Science Fund FWF J 4205
6 · The paper itself

Abstract

Patients with type two diabetes mellitus (T2DM) are at increased risk for cardiovascular diseases. Impairments of endothelin-1 (ET-1) signaling and mTOR pathway have been implicated in diabetic cardiomyopathies. However, the molecular interplay between the ET-1 and mTOR pathway under high glucose (HG) conditions in H9c2 cardiomyoblasts has not been investigated. We employed MTT assay, qPCR, western blotting, fluorescence assays, and confocal microscopy to assess the oxidative stress and mitochondrial damage under hyperglycemic conditions in H9c2 cells. Our results showed that HG-induced cellular stress leads to a significant decline in cell survival and an impairment in the activation of ET

Indexed as

Endothelin-1Myocytes, CardiacGlucoseHumansReceptor, Endothelin AReceptor, Endothelin BSignal TransductionTOR Serine-Threonine KinasesEndothelin-1GlucoseMTOR protein, humanReceptor, Endothelin AReceptor, Endothelin BTOR Serine-Threonine Kinasesendothelin-1ETA-RETB-Rhigh glucosemitochondrial dysfunctionmTORoxidative stress

Identifiers

PMID36430296
PMCPMC9699386
OpenAlexW4308712367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.